Analyst Research: Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

0.41USD
4:00pm EDT
Change (% chg)

$-0.00 (-0.67%)
Prev Close
$0.42
Open
$0.43
Day's High
$0.43
Day's Low
$0.41
Volume
531
Avg. Vol
26,858
52-wk High
$1.22
52-wk Low
$0.36

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - ACASTI PHARMA INC (APO-V) 5:11am EDT Thomson Reuters Stock Report 11 25.00
Acasti Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 1 May 2015 Reuters Investment Profile 12 20.00
ACASTI PHARMA INC (ACST) - REPORT FOR ACTIVE TRADERS 1 May 2015 Pechala's Reports 1 25.00
ACASTI PHARMA INC (ACST) 12-months forecast 1 May 2015 Pechala's Reports 1 15.00
ValuEngine Industry Report for Medical-generic Drugs(ACST) 30 Apr 2015 ValuEngine, Inc. 10 49.00
TheStreet.com Ratings Stock Report For: ACASTI PHARMA INC (ACST) 25 Apr 2015 TheStreet.com Ratings 5 10.00
TheStreet.com Ratings Stock Report For: ACASTI PHARMA INC (ACST) 18 Apr 2015 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

Jerald Wenker

2014 Chairman of the Board

Andre Godin

2014 Interim President and Chief Executive Officer

Pierre Lemieux

2010 Chief Operating Officer

Harlan Waksal

60 2013 Executive Vice President - Business and Scientific Affairs, Director

Tina Sampalis

2012 Chief Global Strategy Officer
Search Stocks